Skip to main content

HER2 testing in metastatic colorectal cancer: ready for prime time?

Publication ,  Journal Article
Hurwitz, HI
Published in: Clin Adv Hematol Oncol
April 2016

Duke Scholars

Published In

Clin Adv Hematol Oncol

ISSN

1543-0790

Publication Date

April 2016

Volume

14

Issue

4

Start / End Page

235 / 237

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Prognosis
  • Oncology & Carcinogenesis
  • Mutation
  • Molecular Targeted Therapy
  • Immunohistochemistry
  • Humans
  • Genetic Variation
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hurwitz, H. I. (2016). HER2 testing in metastatic colorectal cancer: ready for prime time? Clin Adv Hematol Oncol, 14(4), 235–237.
Hurwitz, Herbert I. “HER2 testing in metastatic colorectal cancer: ready for prime time?Clin Adv Hematol Oncol 14, no. 4 (April 2016): 235–37.
Hurwitz HI. HER2 testing in metastatic colorectal cancer: ready for prime time? Clin Adv Hematol Oncol. 2016 Apr;14(4):235–7.
Hurwitz, Herbert I. “HER2 testing in metastatic colorectal cancer: ready for prime time?Clin Adv Hematol Oncol, vol. 14, no. 4, Apr. 2016, pp. 235–37.
Hurwitz HI. HER2 testing in metastatic colorectal cancer: ready for prime time? Clin Adv Hematol Oncol. 2016 Apr;14(4):235–237.

Published In

Clin Adv Hematol Oncol

ISSN

1543-0790

Publication Date

April 2016

Volume

14

Issue

4

Start / End Page

235 / 237

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Prognosis
  • Oncology & Carcinogenesis
  • Mutation
  • Molecular Targeted Therapy
  • Immunohistochemistry
  • Humans
  • Genetic Variation